Skip to main content

Table 2 Statistical Analysis of Therapeutic Response and Prognosis in the Two Groups

From: Oxaliplatin-dacarbazine combination chemotherapy for the treatment of advanced soft tissue sarcoma of the limbs

  

Experimental group (cases)

Control group (cases)

p value

Chemotherapy response

CR

2

1

<0.05

 

PR

11

5

 
 

SD

2

10

 

Surgical margin

Negative

13

6

<0.01

 

Positive

2

10

 

Progression free survival

Yes

10

4

<0.05

 

No

5

12

Â